Product Information

DEXTROAMP-AMPHET ER 20 MG CAP is a generic product labeled by Lannett Company Inc., priced at $0.6200 per EA under NDC 00527079337. Its NADAC has been published 152 times since Dec 27, 2023.

FDA first approved this application on Nov 26, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

5; 5; 5; 5 mg/1; mg/1; mg/1; mg/1

NDC

00527079337

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214403

FDA Approved

11/26/2021

TE Code

AB1

On Market Since

11/26/2021

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 20 MG CAP has been published 152 times since Dec 27, 2023, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6200 per EA
All-time high$0.7112 (Mar 12, 2025)
All-time low$0.4163 (May 22, 2024)
52-week high$0.6379
52-week low$0.5723
Median price$0.6118
Average price$0.6085
Largest weekly change+31.7% (Aug 21, 2024)
Weeks tracked152
Tracking sinceDec 27, 2023

Price History

1W

-0.7%

1M

+3.9%

3M

+4.9%

6M

+4.6%

1Y

-2.8%

3Y

N/A

5Y

N/A

All

+4.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHET ER 20 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 20 MG CAP, manufactured by Lannett Company Inc., is $0.6200 per EA (NDC 00527079337), effective Nov 18, 2026.

How has the price of DEXTROAMP-AMPHET ER 20 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 20 MG CAP has risen 4.7%. It has been tracked across 152 weekly CMS publications since Dec 27, 2023.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 20 MG CAP?

Since Dec 27, 2023, the NADAC for DEXTROAMP-AMPHET ER 20 MG CAP has ranged from a low of $0.4163 (May 22, 2024) to a high of $0.7112 (Mar 12, 2025), with a median of $0.6118 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHET ER 20 MG CAP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 20 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHET ER 20 MG CAP?

DEXTROAMP-AMPHET ER 20 MG CAP (NDC 00527079337) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.